143 related articles for article (PubMed ID: 29272888)
1. Overexpression of SOX11 and TFE3 in Solid-Pseudopapillary Neoplasms of the Pancreas.
Harrison G; Hemmerich A; Guy C; Perkinson K; Fleming D; McCall S; Cardona D; Zhang X
Am J Clin Pathol; 2017 Dec; 149(1):67-75. PubMed ID: 29272888
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies.
Foo WC; Harrison G; Zhang X
Cancer Cytopathol; 2017 Nov; 125(11):831-837. PubMed ID: 29045075
[TBL] [Abstract][Full Text] [Related]
3. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
4. [Expression of SOX-11 and TFE3 in solid-pseudopapillary tumor of pancreas and its clinical significance].
Wang Y; Fu Y; Zheng Z; Wu HY; Zhou Q; Chen KL; Tao Y; Pu XH; Ding J; Wang T; Shi J; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2020 Oct; 49(10):1036-1040. PubMed ID: 32992419
[No Abstract] [Full Text] [Related]
5. [Expression and significance of INSM1 and SOX11 in pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm].
Cao Z; Cen HB; Zhao JH; Mei J; Qin LZ; Liao W; Ao QL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):575-581. PubMed ID: 37534634
[TBL] [Abstract][Full Text] [Related]
6. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
[TBL] [Abstract][Full Text] [Related]
8. CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas.
Lawlor RT; Daprà V; Girolami I; Pea A; Pilati C; Nottegar A; Piccoli P; Parolini C; Sperandio N; Capelli P; Scarpa A; Luchini C
Virchows Arch; 2019 Jan; 474(1):105-109. PubMed ID: 30132130
[TBL] [Abstract][Full Text] [Related]
9. Solid-pseudopapillary neoplasms of the pancreas in men and women: do they differ?
Takahashi Y; Hiraoka N; Onozato K; Shibata T; Kosuge T; Nimura Y; Kanai Y; Hirohashi S
Virchows Arch; 2006 May; 448(5):561-9. PubMed ID: 16523258
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of solid pseudopapillary tumors of the pancreas: the expression pattern of CD99 is highly unique.
Li L; Li J; Hao C; Zhang C; Mu K; Wang Y; Zhang T
Cancer Lett; 2011 Nov; 310(1):9-14. PubMed ID: 21775056
[TBL] [Abstract][Full Text] [Related]
11. Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations.
Dinarvand P; Wang WL; Roy-Chowdhuri S
Cytopathology; 2022 Mar; 33(2):216-221. PubMed ID: 34816516
[TBL] [Abstract][Full Text] [Related]
12. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
[TBL] [Abstract][Full Text] [Related]
13. Nonductal Pancreatic Cancers.
Jun SY; Hong SM
Surg Pathol Clin; 2016 Dec; 9(4):581-593. PubMed ID: 27926361
[TBL] [Abstract][Full Text] [Related]
14. LEF1, TFE3, and AR are putative diagnostic markers of solid pseudopapillary neoplasms.
Kim EK; Jang M; Park M; Kim H
Oncotarget; 2017 Nov; 8(55):93404-93413. PubMed ID: 29212159
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and immunohistochemical study of 29 cases of solid-pseudopapillary neoplasms of the pancreas in patients under 20 years of age along with detailed review of literature.
Din NU; Rahim S; Abdul-Ghafar J; Ahmed A; Ahmad Z
Diagn Pathol; 2020 Dec; 15(1):139. PubMed ID: 33298094
[TBL] [Abstract][Full Text] [Related]
16. Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis.
Meriden Z; Shi C; Edil BH; Ellison T; Wolfgang CL; Cornish TC; Schulick RD; Hruban RH
Am J Surg Pathol; 2011 Jul; 35(7):981-8. PubMed ID: 21677537
[TBL] [Abstract][Full Text] [Related]
17. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.
Argani P; Lal P; Hutchinson B; Lui MY; Reuter VE; Ladanyi M
Am J Surg Pathol; 2003 Jun; 27(6):750-61. PubMed ID: 12766578
[TBL] [Abstract][Full Text] [Related]
18. The Diagnostic and Clinical Significance of TFE3 Immunohistochemical Nuclear Expression in Solitary Fibrous Tumour.
Zhou L; Wang A; Yu G; Zhou J; Xu H; Wang C
Anal Cell Pathol (Amst); 2020; 2020():8232803. PubMed ID: 32566457
[TBL] [Abstract][Full Text] [Related]
19. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
Sangoi AR; Ohgami RS; Pai RK; Beck AH; McKenney JK; Pai RK
Mod Pathol; 2011 Mar; 24(3):412-24. PubMed ID: 20890270
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential.
Kim SA; Kim MS; Kim MS; Kim SC; Choi J; Yu E; Hong SM
Hum Pathol; 2014 Jan; 45(1):166-74. PubMed ID: 24321526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]